Cite
HARVARD Citation
Burmester, G. et al. (2021). Adverse events of special interest in clinical trials of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and psoriasis with 37 066 patient-years of tofacitinib exposure. RMD open. 7 (2), p. . [Online].